Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

被引：0
|
作者：
Ren Sun
Liya Wang
机构：
[1] Swedish University of Agricultural Sciences,Department of Anatomy, Physiology, and Biochemistry
[2] The Biomedical Centre,undefined
来源：
BMC Microbiology | / 13卷
关键词：
Growth inhibition; 6-thioguanine; Trifluorothymidine; Hypoxanthine guanine phosphoribosyl transferase; Thymidine kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs
    Sun, Ren
    Wang, Liya
    BMC MICROBIOLOGY, 2013, 13
  • [2] Review on fluorinated nucleoside/non-nucleoside FDA-approved antiviral drugs
    Ismail, Magda M. F.
    Ayoup, Mohammed Salah
    RSC ADVANCES, 2022, 12 (48) : 31032 - 31045
  • [3] Pan-Pathway Based Interaction Profiling of FDA-Approved Nucleoside and Nucleobase Analogs with Enzymes of the Human Nucleotide Metabolism
    Egeblad, Louise
    Welin, Martin
    Flodin, Susanne
    Graslund, Susanne
    Wang, Liya
    Balzarini, Jan
    Eriksson, Staffan
    Nordlund, Par
    PLOS ONE, 2012, 7 (05):
  • [4] Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobials
    Pertusati, Fabrizio
    Pileggi, Elisa
    Richards, Jennifer
    Wootton, Mandy
    Van Leemputte, Thijs
    Persoons, Leentje
    De Coster, David
    Villanueva, Xabier
    Daelemans, Dirk
    Steenackers, Hans
    McGuigan, Christopher
    Serpi, Michaela
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (10) : 2864 - 2878
  • [5] A systematic analysis of FDA-approved anticancer drugs
    Sun, Jingchun
    Wei, Qiang
    Zhou, Yubo
    Wang, Jingqi
    Liu, Qi
    Xu, Hua
    BMC SYSTEMS BIOLOGY, 2017, 11 : 27 - 43
  • [6] Reviewing the Synthesis and Clinical Application of FDA-Approved Anticancer Medications
    Johariya, Varsha
    Sharma, Shikha
    Mali, Suraj N.
    Banik, Bimal Krishan
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024,
  • [7] Inhibition of HEV Replication by FDA-Approved RdRp Inhibitors
    Hooda, Preeti
    Al-Dosari, Mohammed
    Sinha, Neha
    Parvez, Mohammad K.
    Sehgal, Deepak
    ACS OMEGA, 2023, 8 (44): : 41570 - 41578
  • [8] Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs
    Murono, S
    Raab-Traub, N
    Pagano, JS
    CANCER RESEARCH, 2001, 61 (21) : 7875 - 7877
  • [9] Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma
    Huq, Sakibul
    Casaos, Joshua
    Serra, Riccardo
    Peters, Michael
    Xia, Yuanxuan
    Ding, Andy S.
    Ehresman, Jeff
    Kedda, Jayanidhi N.
    Morales, Manuel
    Gorelick, Noah L.
    Zhao, Tianna
    Ishida, Wataru
    Perdomo-Pantoja, Alexander
    Cecia, Arba
    Ji, Chenchen
    Suk, Ian
    Sidransky, David
    Brait, Mariana
    Brem, Henry
    Skuli, Nicolas
    Tyler, Betty
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (09) : 1797 - 1808
  • [10] Repositioning the FDA-approved antiviral drug ribavirin as targeted therapy for nasopharyngeal carcinoma
    Huq, Sakibul
    Casaos, Joshua
    Peters, Michael
    Xia, Yuanxuan
    Ding, Andy
    Morales, Manuel
    Gorelick, Noah
    Serra, Riccardo
    Zhao, Tianna
    Ishida, Wataru
    Perdomo-Pantoja, Alexander
    Cecia, Arba
    Ji, Chenchen
    Suk, Ian
    Sidransky, David
    Brait, Mariana
    Brem, Henry
    Skuli, Nicolas
    Tyler, Betty
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 54 - 54
12345